China is the top 3 drug market in 2010_Financial Times indicated..

With respect of China medical reform and domestic stimulus plan, China definitely becomes the most speedy booming pharmaceutical market in the world. At this moment, almost developed countries are bothered by increasingly burden for health expense and cutting the drug price sounds of a trendy among them. But China is still favoring the western-level price for patent drugs. doubtlessly, China authority intends to attract profit-hungry investors (offshore) and more cutting edge technology transfer. Even China encountered currency pressure, there is limited effect on its domestic demand and foreign investment.

 

      IMS data typically examine gross sales, ahead of a complex range of discounts, especially in the US, with the result that the sales reported by drug companies – and their margins – are often lower than publicly quoted figures. The IMS data predict that China's sales for 2010 will be $42bn, edging ahead of $38.7bn in Germany. They will, however, still lag far behind the US – the world's largest market – at $301.3bn and Japan, at $93.2bn. The 2010 estimates put France in fifth place, with sales of $37.8bn, followed by Italy, Canada, Brazil, Spain and the UK.